RIPK3 and infection: Using systematic cellular assays and animal infection models, we demonstrated that the nanodrug effectively modulates the ZBP1-RIPK3-MLKL-caspase signaling axis, significantly inhibiting apoptosis, necroptosis, and pyroptosis.